ACRS vs AAPL: Which Stock is Better?
Side-by-side comparison of Aclaris Therapeutics Inc and Apple Inc in 2026
ACRS
Aclaris Therapeutics Inc
$4.43
AAPL
Apple Inc
$246.86
Key Metrics Comparison
| Metric | ACRS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $283.86M | $3.66T | AAPL |
| P/E Ratio | N/A | 33.11 | AAPL |
| EPS (TTM) | $N/A | $7.45 | AAPL |
| Revenue Growth | -0.2% | 0.1% | AAPL |
| Gross Margin | -275.7% | 46.9% | AAPL |
Analyze ACRS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRS or AAPL a better investment?
Comparing ACRS and AAPL: Aclaris Therapeutics Inc has a market cap of $283.86M while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRS and AAPL?
ACRS (Aclaris Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRS or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRS or AAPL?
AAPL has higher revenue growth at 0.1% vs -0.2% for ACRS.
Which company is more profitable: ACRS or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to -275.7% for ACRS.
Which is the larger company: ACRS or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $283.86M for ACRS.
Should I buy ACRS or AAPL in 2026?
Both ACRS and AAPL have investment merit. ACRS trades at $4.43 while AAPL trades at $246.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRS and AAPL stock?
Key differences: Market Cap ($283.86M vs $3.66T), P/E Ratio (N/A vs 33.1x), Revenue Growth (-0.2% vs 0.1%), Gross Margin (-275.7% vs 46.9%).